These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3099750)

  • 1. Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.
    Prandini MH; Reboul A; Colomb MG
    Biochem J; 1986 Jul; 237(1):93-8. PubMed ID: 3099750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of C1q, C1s and C-1 Inh synthesized by stimulated human monocytes in vitro.
    Reboul A; Prandini MH; Bensa JC; Colomb MG
    FEBS Lett; 1985 Oct; 190(1):65-8. PubMed ID: 3876244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tunicamycin and endoglycosidase H and F on the estrogen regulated 52000-Mr protein secreted by breast cancer cells.
    Touitou I; Garcia M; Westley B; Capony F; Rochefort H
    Biochimie; 1985 Dec; 67(12):1257-66. PubMed ID: 3938296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.
    Donaldson VH; Wagner CJ; Tsuei B; Kindness G; Bing DH; Harrison RA; Rosen FS
    Blood; 1987 Apr; 69(4):1096-101. PubMed ID: 3493816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.
    Reboul A; Bensa JC; Colomb MG
    Biochem J; 1986 Jan; 233(2):559-64. PubMed ID: 3006672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.
    He S; Sim RB; Whaley K
    Mol Med; 1998 Feb; 4(2):119-28. PubMed ID: 9508789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.
    Donaldson VH; Harrison RA; Rosen FS; Bing DH; Kindness G; Canar J; Wagner CJ; Awad S
    J Clin Invest; 1985 Jan; 75(1):124-32. PubMed ID: 3965500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.
    Montalvo EA; Parmley RT; Grose C
    J Virol; 1985 Mar; 53(3):761-70. PubMed ID: 2983087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.
    Bos IG; van Mierlo GJ; Bleeker WK; Rigter GM; te Velthuis H; Dickneite G; Hack CE
    Int Immunopharmacol; 2001 Aug; 1(8):1583-95. PubMed ID: 11515821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, intracellular processing and secretion of thrombospondin in human endothelial cells.
    Vischer P; Beeck H; Voss B
    Eur J Biochem; 1985 Dec; 153(3):435-43. PubMed ID: 3935437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
    Nilsson T; Bäck O
    Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.
    Hawkins LK; Wold WS
    Virology; 1995 Jul; 210(2):335-44. PubMed ID: 7618271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation of thyroid-stimulating hormone in pituitary tumor cells: influence of high mannose oligosaccharide units on subunit aggregation, combination, and intracellular degradation.
    Weintraub BD; Stannard BS; Meyers L
    Endocrinology; 1983 Apr; 112(4):1331-45. PubMed ID: 6403327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.